FDA.reportPublic FDA data

Application 202040

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ELETRIPTAN HYDROBROMIDEELETRIPTAN HYDROBROMIDETABLET;ORALEQ 20MG BASENoNo
002ELETRIPTAN HYDROBROMIDEELETRIPTAN HYDROBROMIDETABLET;ORALEQ 40MG BASENoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0093-8310Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8310Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8310Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8310Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8310Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8310Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8311Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8311Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8311Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8311Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8311Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent
0093-8311Eletriptan HydrobromideEletriptan HydrobromideTeva Pharmaceuticals USA, Inc.ANDACurrent